Area of research
Oncology · Pathology and Forensic Medicine
Research interest
Research interests include Colorectal Cancer Treatments and Studies, Genetic factors in colorectal cancer, Glioma Diagnosis and Treatment, and Cancer Cells and Metastasis.
ADAMTS18+ villus tip telocytes maintain a polarized VEGFA signaling domain and fenestrations in nutrient-absorbing intestinal blood vessels
70-gene signature as an aid for treatment decisions in early breast cancer: updated results of the phase 3 randomised MINDACT trial with an exploratory analysis by age
The Interleukin 22 Pathway Interacts with Mutant KRAS to Promote Poor Prognosis in Colon Cancer
Clinical utility of MammaPrint testing in Invasive Lobular Carcinoma: Results from the MINDACT phase III trial
Cooperation between Constitutive and Inducible Chemokines Enables T Cell Engraftment and Immune Attack in Solid Tumors
TOX reinforces the phenotype and longevity of exhausted T cells in chronic viral infection
RasGRP1 is a potential biomarker for stratifying anti-EGFR therapy response in colorectal cancer
The DNA methylome of DDR genes and benefit from RT or TMZ in IDH mutant low-grade glioma treated in EORTC 22033
Modulation of the peripheral blood transcriptome by the ingestion of probiotic yoghurt and acidified milk in healthy, young men
Ex vivo drug response profiling detects recurrent sensitivity patterns in drug-resistant acute lymphoblastic leukemia
70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer
Somatic POLE proofreading domain mutation, immune response, and prognosis in colorectal cancer: a retrospective, pooled biomarker study
<i>BRAF</i> <i>V600E</i> Mutant Colorectal Cancer Subtypes Based on Gene Expression
A Vulnerability of a Subset of Colon Cancers with Potential Clinical Utility
The consensus molecular subtypes of colorectal cancer
Genomics and drug profiling of fatal TCF3-HLF−positive acute lymphoblastic leukemia identifies recurrent mutation patterns and therapeutic options
Cancer cell–autonomous contribution of type I interferon signaling to the efficacy of chemotherapy
Distal and proximal colon cancers differ in terms of molecular, pathological, and clinical features
Prognosis of stage II and III colon cancer treated with adjuvant 5-fluorouracil or FOLFIRI in relation to microsatellite status: results of the PETACC-3 trial
The Hippo Transducer YAP1 Transforms Activated Satellite Cells and Is a Potent Effector of Embryonal Rhabdomyosarcoma Formation
Colorectal Cancer Subtyping Consortium (CRCSC) identification of a consensus of molecular subtypes.
Colorectal Cancer Subtyping Consortium (CRCSC) Identifies Consensus of Molecular Subtypes
Gene expression patterns unveil a new level of molecular heterogeneity in colorectal cancer
Context-dependent interpretation of the prognostic value of BRAF and KRAS mutations in colorectal cancer
Identification of a Poor-Prognosis<i>BRAF</i>-Mutant–Like Population of Patients With Colon Cancer
Genome-Wide RNA Polymerase II Profiles and RNA Accumulation Reveal Kinetics of Transcription and Associated Epigenetic Changes During Diurnal Cycles
A Comprehensive Characterization of Genome-Wide Copy Number Aberrations in Colorectal Cancer Reveals Novel Oncogenes and Patterns of Alterations
A robust genomic signature for the detection of colorectal cancer patients with microsatellite instability phenotype and high mutation frequency